Sotera Health Company SHC
16.53 USD +0.25 (+1.57%)
Nov 11, 2026, 11:10 AM EST
16.18 Day range 16.54
13.09 52-week range 19.85
- YTD
- -6.32%
- 1 year
- +2.45%
News
benzinga.com JP Morgan Maintains Underweight on Sotera Health, Lowers Price Target to $15 JP Morgan analyst Casey Woodring maintains Sotera Health (NASDAQ:SHC) with a Underweight and lowers the price target from $17 to $15.
benzinga.com Barclays Maintains Overweight on Sotera Health, Lowers Price Target to $20 Barclays analyst Luke Sergott maintains Sotera Health (NASDAQ:SHC) with a Overweight and lowers the price target from $22 to $20.
benzinga.com Sotera Health Q3 2026 Earnings Call Transcript Sotera Health (NASDAQ:SHC) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you…
benzinga.com Sotera Health Q3 Adj. EPS $0.29 Beats $0.27 Estimate, Sales $324.886M Beat $319.774M Estimate Sotera Health (NASDAQ:SHC) reported quarterly earnings of $0.29 per share which beat the analyst consensus estimate of $0.27 by 7.41 percent. This is a 11.54 percent increase over earnings of $0.26…
benzinga.com Sotera Health Affirms FY2026 Adj EPS Guidance of $0.95-$1.01 vs $0.98 Est; Lowers FY2026 Sales Guidance from $1.236B-$1.254B to $1.233B-$1.250B vs $1.247B Est Sotera Health (NASDAQ:SHC) affirms FY2026 Adj EPS guidance from $0.95-$1.01 to $0.95-$1.01 vs $0.98 analyst estimate. Lowers FY2026 sales outlook from $1.236 billion-$1.254 billion to $1.233…- benzinga.com JP Morgan Downgrades Sotera Health to Underweight, Announces $17 Price Target JP Morgan analyst Casey Woodring downgrades Sotera Health (NASDAQ:SHC) from Neutral to Underweight and announces $17 price target.
benzinga.com Transcript: Sotera Health Q2 2026 Earnings Conference Call Sotera Health (NASDAQ:SHC) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call…
benzinga.com Citigroup Maintains Buy on Sotera Health, Raises Price Target to $25 Citigroup analyst Brendan Digan maintains Sotera Health (NASDAQ:SHC) with a Buy and raises the price target from $23 to $25.
benzinga.com Barclays Maintains Overweight on Sotera Health, Raises Price Target to $22 Barclays analyst Luke Sergott maintains Sotera Health (NASDAQ:SHC) with a Overweight and raises the price target from $19 to $22.- benzinga.com Piper Sandler Reiterates Overweight on Sotera Health, Raises Price Target to $25 Piper Sandler analyst Jason Bednar reiterates Sotera Health (NASDAQ:SHC) with a Overweight and raises the price target from $22 to $25.
- benzinga.com JP Morgan Maintains Neutral on Sotera Health, Raises Price Target to $18 JP Morgan analyst Casey Woodring maintains Sotera Health (NASDAQ:SHC) with a Neutral and raises the price target from $16 to $18.
- benzinga.com Sotera Health Q2 Adj. EPS $0.26 Beats $0.24 Estimate, Sales $321.375M Beat $309.391M Estimate Sotera Health (NASDAQ:SHC) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.24 by 8.33 percent. This is a 30 percent increase over earnings of $0.20 per…
benzinga.com Sotera Health Raises FY2026 Adj EPS Guidance from $0.93-$1.01 to $0.95-$1.01 vs $0.97 Est; Raises FY2026 Sales Guidance from $1.233B-$1.251B to $1.236B-$1.254B vs $1.241B Est Sotera Health (NASDAQ:SHC) raises FY2026 Adj EPS guidance from $0.93-$1.01 to $0.95-$1.01 vs $0.97 analyst estimate. Raises FY2026 sales outlook from $1.233 billion-$1.251 billion to $1.236…- benzinga.com Barclays Maintains Overweight on Sotera Health, Raises Price Target to $19 Barclays analyst Luke Sergott maintains Sotera Health (NASDAQ:SHC) with a Overweight and raises the price target from $18 to $19.
benzinga.com This Onto Innovation Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday Top Wall Street analysts changed outlook for top names. See all changes on analyst ratings page. ONTO rated Buy with $350 PT by Deutsche Bank.
benzinga.com Earnings Scheduled For May 5, 2026 
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session - benzinga.com Earnings Scheduled For February 24, 2026
- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com Earnings Scheduled For November 4, 2025 
benzinga.com SoundHound AI, Ouster, Globalstar, Doximity, JFrog And Other Big Stocks Moving Higher On Friday 
benzinga.com Earnings Scheduled For August 8, 2025 - benzinga.com Earnings Scheduled For May 1, 2025
- benzinga.com Earnings Scheduled For February 27, 2025
- benzinga.com G-III Apparel Posts Upbeat Results, Joins NIO, Yext, Shoe Carnival And Other Big Stocks Moving Higher On Thursday
- benzinga.com Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession…
- benzinga.com Earnings Scheduled For February 27, 2024 Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.
benzinga.com Acuity Brands Posts Upbeat Earnings, Joins Accolade, Urban Outfitters And Other Big Stocks Moving Higher On Tuesday U.S. stocks traded lower, with the Dow Jones index falling over 250 points on Tuesday.
benzinga.com Earnings Scheduled For November 1, 2023 Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion.- benzinga.com Earnings Scheduled For August 3, 2023 Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For June 26, 2023
- benzinga.com Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session Gainers Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) shares climbed 422% to $0.5572 after the company announced acquisition of Spyre Therapeutics and concurrent oversubscribed $210 million private…
- benzinga.com Steelcase, Commercial Metals And Other Big Stocks Moving Higher On Thursday U.S. stocks traded mixed, with the Dow Jones dropping around 50 points on Thursday. Here are some big stocks recording gains in today’s session.
- benzinga.com Earnings Scheduled For February 28, 2023 Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter.
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For January 23, 2023
- benzinga.com Why TuanChe Shares Are Trading Lower By 76%? Here Are 48 Stocks Moving In Monday's Mid-Day Session Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares jumped 104% to $35.50 after Merck announced it would acquire the company for $36 per share in cash.
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022 Upgrades
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 283 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday Friday's session saw 236 companies set new 52-week lows.
- benzinga.com Earnings Scheduled For November 2, 2022 Companies Reporting Before The Bell • Nomura Holdings (NYSE:NMR) is likely to report earnings for its second quarter.
- benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 413 companies reached new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 838 companies hit new 52-week lows.
- benzinga.com Why Nauticus Robotics Shares Are Trading Higher By 96%; Here Are 67 Biggest Movers From Yesterday Gainers Chardan NexTech Acquisition 2 Corp. (NASDAQ: CNTQ) shares surged 102.6% to close at $21.54 on Wednesday.
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2022 Upgrades
- benzinga.com Stocks That Hit 52-Week Lows On Monday During Monday's session, 402 companies made new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 930 stocks hit new 52-week lows.
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For September 26, 2022 Upgrades
- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 1076 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 340 stocks hit new 52-week lows.
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2022 Upgrades For Berkshire Hathaway Inc (NYSE:BRK), Edward Jones upgraded the previous rating of Hold to Buy. Berkshire Hathaway earned $6312.49 in the second quarter, compared to $4399.91 in the…